Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder

The acute treatment duration for major depressive disorder (MDD) is 8 weeks or more. Treatment of patients with MDD without predictors of treatment response and future recurrence presents challenges and clinical problems to patients and physicians. Recently, many neuroimaging studies have been publi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2020-03, Vol.21 (6), p.2148
Hauptverfasser:	Kang, Seung-Gul, Cho, Seo-Eun
Format:	Artikel
Sprache:	eng
Schlagworte:	Accuracy Antidepressants Biomarkers Biomarkers - metabolism Brain research Computed tomography Depressive Disorder, Major - diagnostic imaging Depressive Disorder, Major - genetics Depressive Disorder, Major - therapy Electroconvulsive therapy Emotional behavior Functional magnetic resonance imaging Genomes Humans Infrared imaging Infrared spectra Infrared spectroscopy Insomnia Machine Learning Magnetic resonance imaging Magnetic resonance spectroscopy Medical imaging Mental depression Mental disorders Near infrared radiation Neuroimaging Patients Photon emission Physicians Positron emission Positron emission tomography Precision medicine Recurrence Review Single photon emission computed tomography Sleep Spectrum analysis Studies Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!